Go Pro

Invesco Biotechnology & Genome ETF (PBE) Institutional Ownership

Invesco Biotechnology & Genome ETF logo
$96.27 -1.40 (-1.43%)
Closing price 09/23/2026 04:10 PM Eastern
Extended Trading
$96.20 -0.07 (-0.07%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Number of
Institutional Buyers
(last 12 months)
36
Total
Institutional Inflows
(last 12 months)
$40.43M
Number of
Institutional Sellers
(last 12 months)
25
Total
Institutional Outflows
(last 12 months)
$17.63M
Get PBE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Invesco Biotechnology & Genome ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PBE Institutional Buying and Selling by Quarter

Invesco Biotechnology & Genome ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/23/2026 Envestnet Asset Management Inc.22,250$2.00M0.0%+4.2%0.510%
9/9/2026 Archford Capital Strategies LLC6,252$560K0.1%+6.7%0.198%
9/9/2026 Integrated Wealth Concepts LLC942$84K0.0%N/A0.030%
9/9/2026 NewEdge Advisors LLC648$58K0.0%-40.6%0.021%
9/2/2026 Citadel Advisors LLC4,999$448K0.0%-41.7%0.159%
8/22/2026 Compass Financial Management LLC300$27K0.0%N/A0.010%
8/12/2026 Compass Financial Management LLC300$27K0.0%N/A0.010%
7/7/2026 Dynamic Advisor Solutions LLC5,398$484K0.0%N/A0.174%
5/19/2026 Bank of America Corp DE59,290$4.70M0.0%-4.0%1.906%
5/18/2026 Royal Bank of Canada59,329$4.70M0.0%+25.9%1.908%
5/13/2026 Cetera Investment Advisers23,139$1.83M0.0%+2.0%0.744%
5/1/2026 Fifth Third Bancorp378$30K0.0%N/A0.012%
4/30/2026 Kestra Advisory Services LLC6,280$497K0.0%+7.0%0.201%
4/22/2026 Janney Montgomery Scott LLC3,830$303K0.0%-9.0%0.122%
3/17/2026 Rockefeller Capital Management L.P.10,666$876K0.0%+6.7%0.332%
2/18/2026 NewEdge Advisors LLC1,043$86K0.0%+18.1%0.032%
2/18/2026 VestGen Advisors LLC2,610$214K0.0%-44.3%0.081%
2/17/2026 Cetera Investment Advisers22,675$1.86M0.0%+3.1%0.706%
2/17/2026 GeoWealth Management LLC2,010$165K0.0%-23.3%0.063%
2/17/2026 Osaic Holdings Inc.8,963$736K0.0%-4.8%0.279%
2/17/2026 Royal Bank of Canada47,114$3.87M0.0%-0.6%1.468%
2/16/2026 MML Investors Services LLC2,497$205K0.0%N/A0.078%
2/13/2026 CreativeOne Wealth LLC11,384$935K0.0%-4.5%0.355%
2/13/2026 Stifel Financial Corp6,409$526K0.0%-6.3%0.200%
2/13/2026 Wells Fargo & Company MN46,856$3.85M0.0%-0.7%1.460%
2/13/2026 Gerber Kawasaki Wealth & Investment Management42,909$3.53M0.1%-7.0%1.337%
2/12/2026 Commonwealth Equity Services LLC21,913$1.80M0.0%-12.4%0.683%
2/12/2026 Steward Partners Investment Advisory LLC1,250$103K0.0%+51.5%0.039%
2/12/2026 Moneta Group Investment Advisors LLC2,718$223K0.0%N/A0.085%
2/12/2026 Colonial Trust Advisors304$25K0.0%N/A0.009%
2/11/2026 Janney Montgomery Scott LLC4,208$346K0.0%-3.1%0.131%
2/11/2026 LPL Financial LLC97,304$7.99M0.0%+5.0%3.031%
2/11/2026 Wharton Business Group LLC2,739$225K0.0%N/A0.085%
2/10/2026 One Capital Management LLC9,687$796K0.0%-5.0%0.302%
2/10/2026 Northwestern Mutual Wealth Management Co.2,335$192K0.0%-36.9%0.073%
2/9/2026 Harbour Investments Inc.519$43K0.0%-25.4%0.016%
2/5/2026 Northwestern Mutual Wealth Management Co.342,971$28.18M0.0%+9,169.5%10.684%
2/5/2026 Western Wealth Management LLC2,731$224K0.0%N/A0.085%
2/5/2026 Pacific Sun Financial Corp4,847$398K0.2%-6.5%0.151%
2/3/2026 RFG Advisory LLC8,455$695K0.0%+6.6%0.263%
Elon gets it. Do you? (Ad)

Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel

Stream the free Ignition Point broadcast for the full biotech breakdown.
1/29/2026Comerica Bank378$31K0.0%+86.2%0.012%
1/29/2026 UBS Group AG67,361$5.53M0.0%-6.5%2.098%
1/27/2026 Q3 Asset Management17,429$1.43M0.3%N/A0.543%
1/27/2026 Institute for Wealth Management LLC.20,268$1.67M0.2%-2.4%0.631%
1/26/2026 Massachusetts Wealth Management17,919$1.47M0.7%-2.3%0.560%
1/22/2026 Newman Dignan & Sheerar Inc.10,070$827K0.2%+3.0%0.316%
1/20/2026 Stratos Wealth Partners LTD.3,165$260K0.0%N/A0.099%
1/9/2026 BOS Asset Management LLC2,439$200K0.1%N/A0.077%
1/8/2026 Wealth Enhancement Advisory Services LLC4,562$383K0.0%-4.0%0.144%
1/8/2026Signet Financial Management LLC3,299$271K0.0%-10.5%0.104%
1/7/2026 Harbor Investment Advisory LLC1,275$105K0.0%+750.0%0.040%
11/18/2025 Advisory Services Network LLC1,173$82K0.0%N/A0.037%
11/17/2025 NewEdge Advisors LLC883$62K0.0%+63.2%0.028%
11/17/2025 United Capital Financial Advisors LLC85,095$5.95M0.0%N/A2.719%
11/17/2025 Citadel Advisors LLC2,953$206K0.0%N/A0.094%
11/17/2025 Bank of America Corp DE59,918$4.19M0.0%+2.5%1.914%
11/14/2025 Raymond James Financial Inc.8,078$564K0.0%+1.8%0.258%
11/14/2025 One Capital Management LLC10,200$713K0.0%-20.5%0.326%
11/13/2025 Pacific Sun Financial Corp5,185$362K0.2%-7.7%0.166%
11/13/2025 GeoWealth Management LLC2,621$183K0.0%-7.5%0.084%
11/13/2025 UBS Group AG72,025$5.03M0.0%-5.2%2.301%
11/13/2025 Gerber Kawasaki Wealth & Investment Management46,137$3.22M0.1%-81.8%1.474%
11/13/2025 CreativeOne Wealth LLC11,916$833K0.0%-22.3%0.381%
11/13/2025 Blair William & Co. IL1,000$70K0.0%+150.0%0.032%
11/10/2025 Abbot Financial Management Inc.12,425$868K0.4%-2.4%0.397%
11/7/2025Signet Financial Management LLC3,687$258K0.0%-15.3%0.118%
11/7/2025 PNC Financial Services Group Inc.574$40K0.0%+74.5%0.018%
11/6/2025 RFG Advisory LLC7,934$554K0.0%+69.4%0.253%
11/5/2025 Envestnet Asset Management Inc.19,723$1.38M0.0%+7.7%0.630%
10/31/2025 Investment House LLC8,580$599K0.0%+14.7%0.274%
10/30/2025 Joel Isaacson & Co. LLC3,025$211K0.0%N/A0.097%
10/17/2025 Archford Capital Strategies LLC3,189$223K0.0%-13.1%0.102%
10/17/2025 Sowell Financial Services LLC2,980$208K0.0%N/A0.095%
10/9/2025 Newman Dignan & Sheerar Inc.9,772$683K0.1%-6.7%0.311%
9/4/2025 Osaic Holdings Inc.9,441$605K0.0%+9.9%0.274%
8/15/2025 IHT Wealth Management LLC15,339$983K0.0%-1.4%0.445%
8/15/2025 Bank of America Corp DE58,465$3.75M0.0%-11.4%1.695%
8/15/2025 Abbot Financial Management Inc.12,725$816K0.4%-3.6%0.369%
8/14/2025 Raymond James Financial Inc.7,937$509K0.0%-12.7%0.230%
8/14/2025 Investment House LLC7,480$479K0.0%-6.3%0.217%
8/14/2025 Gerber Kawasaki Wealth & Investment Management254,172$16.29M0.6%+4.2%7.367%
8/13/2025 VestGen Advisors LLC4,704$313K0.0%-6.9%0.136%
8/12/2025 CreativeOne Wealth LLC15,333$983K0.0%-14.3%0.444%
8/12/2025 JPMorgan Chase & Co.501$32K0.0%-93.6%0.015%
8/8/2025 Cetera Investment Advisers20,398$1.31M0.0%-3.4%0.591%
8/8/2025 Creative Planning3,223$207K0.0%-81.5%0.093%
8/7/2025 Allworth Financial LP850$54K0.0%N/A0.025%
8/5/2025 Hills Bank & Trust Co4,887$313K0.0%-6.3%0.142%
8/4/2025 Creative Financial Designs Inc. ADV2,971$190K0.0%-32.8%0.086%
7/30/2025 Pacific Sun Financial Corp5,618$360K0.2%-7.0%0.163%
Iran War TRUTH: What Two Congressmen Led Me To (Ad)

Two private meetings with U.S. Congressmen on March 2nd, three days after the first missiles fell, sent one analyst down an unexpected research trail. The investigation uncovered a coordinated operation, a shadow group running it, and one company sitting at the center of it all.tc pixel

Click here to uncover the strategy behind the Iran war.
7/28/2025 RFG Advisory LLC4,684$300K0.0%N/A0.136%
7/28/2025 Axxcess Wealth Management LLC4,725$303K0.0%-10.4%0.137%
7/23/2025 Massachusetts Wealth Management18,394$1.18M0.7%+1.0%0.530%
7/18/2025 Newman Dignan & Sheerar Inc.10,472$671K0.2%-3.7%0.302%
7/17/2025 Janney Montgomery Scott LLC5,080$326K0.0%-6.3%0.146%
7/17/2025 Archford Capital Strategies LLC3,669$235K0.0%-19.2%0.106%
7/16/2025 Dakota Wealth Management4,901$314K0.0%-38.5%0.141%
7/15/2025Signet Financial Management LLC4,351$279K0.0%+3.9%0.125%
7/10/2025 YHB Investment Advisors Inc.24,256$1.56M0.1%-1.0%0.697%
7/10/2025 Wealth Enhancement Advisory Services LLC4,751$312K0.0%-34.4%0.137%


PBE Institutional Ownership - Frequently Asked Questions

During the previous two years, 83 institutional investors and hedge funds held shares of Invesco Biotechnology & Genome ETF. The most heavily invested institutionals were LPL Financial LLC ($7.99M), United Capital Financial Advisors LLC ($5.95M), UBS Group AG ($5.53M), Royal Bank of Canada ($4.70M), Bank of America Corp DE ($4.70M), Wells Fargo & Company MN ($3.85M), and Gerber Kawasaki Wealth & Investment Management ($3.53M).Learn more on Invesco Biotechnology & Genome ETF's institutional investors.

Of the 59 institutional investors that purchased Invesco Biotechnology & Genome ETF's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Northwestern Mutual Wealth Management Co. ($340.22K), United Capital Financial Advisors LLC ($85.10K), Raymond James Financial Inc. ($37.90K), Gerber Kawasaki Wealth & Investment Management ($37.13K), Royal Bank of Canada ($25.98K), Q3 Asset Management ($17.43K), and Citadel Advisors LLC ($11.50K).

Institutional investors have bought a total of 507,416 shares in the last 24 months. This purchase volume represents approximately $40.43M in transactions.

Of the 25 institutional investors that sold Invesco Biotechnology & Genome ETF's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Gerber Kawasaki Wealth & Investment Management ($211.26K), UBS Group AG ($8.62K), CreativeOne Wealth LLC ($3.95K), Citadel Advisors LLC ($3.57K), One Capital Management LLC ($3.14K), Commonwealth Equity Services LLC ($3.09K), and Bank of America Corp DE ($2.44K).

Institutional investors have sold a total of 247,390 shares in the last 24 months. This volume of shares sold represents approximately $17.63M in transactions.



Institutional ownership data for NYSEARCA:PBE is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/23/2026. New 13F filings are added each quarter as they're published.
From Our Partners